References
- HardenCLMeadorKJPennellPBPractice parameter update: management issues for women with epilepsy – focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy SocietyNeurology200973213314119398681
- MorrellMJEpilepsy in womenAm Fam Physician20026681489149412408423
- Epilepsy FoundationRisks during pregnancy2014 Available from: http://www.epilepsy.com/learn/impact/reproductive-risks/risks-during-pregnancyAccessed June 19, 2016
- Epilepsy FoundationEpilepsy and pregnancy2014 Available from: http://www.epilepsy.com/information/women/epilepsy-and-pregnancyAccessed June 19, 2016
- FairgrieveSDJacksonMJonasPPopulation based, prospective study of the care of women with epilepsy in pregnancyBMJ2000321726267467510987772
- CagnettiCLattanziSFoschiNProvincialiLSilvestriniMSeizure course during pregnancy in catamenial epilepsyNeurology201483433934424944265
- BattinoDTomsonTBonizzoniESeizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registryEpilepsia20135491621162723848605
- La NeveABoeroGFrancavillaTPlantamuraMDe AgazioGSpecchioLMProspective, case-control study on the effect of pregnancy on seizure frequency in women with epilepsyNeurol Sci2015361798325070383
- EdeySMoranNNashefLSUDEP and epilepsy-related mortality in pregnancyEpilepsia2014557e72e7424754364
- MacDonaldSCBatemanBTMcElrathTFHernandez-DiazSMortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United StatesJAMA Neurol201572998198826147878
- BorthenIObstetrical complications in women with epilepsySeizure201528323425843764
- VialeLAlloteyJCheong-SeeFEpilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysisLancet2015386100061845185226318519
- TomsonTXueHBattinoDMajor congenital malformations in children of women with epilepsySeizure201528465025777785
- Food and Drug AdministrationPregnancy and lactation labeling (drugs) final rule2014 Available from: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/Labeling/ucm093307.htmAccessed June 19, 2016
- KwanPBrodieMJEpilepsy after the first drug fails: substitution or add-on?Seizure20009746446811034869
- StephenLJBrodieMJSeizure freedom with more than one antiepileptic drugSeizure200211634935112160660
- GjerdeIOStrandjordREUlsteinMThe course of epilepsy during pregnancy: a study of 78 casesActa Neurol Scand19887831982053147566
- TomsonTLindbomUEkqvistBSundqvistAEpilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoinEpilepsia19943511221308112234
- VajdaFJHitchcockAGrahamJO’BrienTLanderCEadieMSeizure control in antiepileptic drug-treated pregnancyEpilepsia200849117217618031551
- ReisingerTLNewmanMLoringDWPennellPBMeadorKJAntiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsyEpilepsy Behav2013291131823911354
- ShresthaAWongPSBainbridgePSBridging the knowledge gap in women with epilepsy of childbearing potential: impact of a multidisciplinary counseling and prenatal care clinicPresented at: Program and abstracts of the 69th Annual Meeting of the American Epilepsy SocietyDecember 4–8, 2015Philadelphia, PA Abstract 1.342
- HolmesLBMittendorfRShenASmithCRHernandez-DiazSFetal effects of anticonvulsant polytherapies: different risks from different drug combinationsArch Neurol201168101275128121670385
- Hernandez-DiazSSmithCRShenAComparative safety of antiepileptic drugs during pregnancyNeurology201278211692169922551726
- MaheshwariAAthaleSLekhraOPComparative safety of antiepileptic drugs during pregnancyNeurology201380768923400320
- MeadorKJEpilepsy: pregnancy in women with epilepsy – risks and managementNat Rev Neurol2014101161461625266298
- JentinkJLoaneMADolkHValproic acid monotherapy in pregnancy and major congenital malformationsN Engl J Med2010362232185219320558369
- VajdaFJO’BrienTLanderCGrahamJEadieMThe efficacy of the newer antiepileptic drugs in controlling seizures in pregnancyEpilepsia20145581229123424995555
- VajdaFLanderCO’BrienTAustralian pregnancy registry of women taking antiepileptic drugsEpilepsia200445146615509252
- CrawfordPBest practice guidelines for the management of women with epilepsyEpilepsia200546Suppl 911712416302885
- GerardEEMeadorKJManaging epilepsy in womenContinuum (Minneap Minn)201622120422626844738
- EricksonSCLeLRamseySDClinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsyEpilepsia20115271365137121692778
- TingTYJiangWLionbergerRGeneric lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: a field test of the FDA bioequivalence standardEpilepsia20155691415142426201987
- PriviteraMDWeltyTEGidalBEGeneric-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialLancet Neurol201615436537226875743
- VosslerDAndersonGBainbridgeJAES Position Statement on Generic Substitution of Antiepileptic DrugsEpilepsy Curr201616320921127330454
- BerkovicSFHowellRAHayDAHopperJLEpilepsies in twins: genetics of the major epilepsy syndromesAnn Neurol19984344354459546323
- HansonRLHabibiMKhamoNAbdouSStubbingsJIntegrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosisAm J Health Syst Pharm201471646346924589537
- HabibiMKuttabHMManagement of multiple sclerosis and the integration of related specialty pharmacy programs within health systemsAm J Health Syst Pharm2016731181181927126827
- AndersonGDUsing pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactationExpert Opin Drug Metab Toxicol20062694796017125410
- Centers for Disease Control and PreventionU.S. medical eligibility criteria for contraceptive use, 2010MMWR Recomm Rep201059RR-4186
- Centers for Disease Control and PreventionUpdate to CDC’s U.S. medical eligibility criteria for contraceptive use, 2010: revised recommendations for the use of contraceptive methods during the postpartum periodMMWR Morb Mortal Wkly Rep2011602687888321734635
- FountainNBVan NessPCBennettAQuality improvement in neurology: epilepsy update quality measurement setNeurology201584141483148725846995
- NakatsukaTKomatsuTFujiiTAxial skeletal malformations induced by acetazolamide in rabbitsTeratology19924566296361412055
- WorshamFJrBeckmanENMitchellEHSacrococcygeal teratoma in a neonate. Association with maternal use of acetazolamideJAMA19782403251252660854
- McBrideWGThe teratogenic action of drugsMed J Aust1963268969214069005
- MillerTAScottWJJrAbnormalities in ureter and kidney development in mice given acetazolamide-amiloride or dimethadione (DMO) during embryogenesisTeratology19924665415501290154
- MerlobPLitwinAMorNPossible association between acetazolamide administration during pregnancy and metabolic disorders in the newbornEur J Obstet Gynecol Reprod Biol199035185882311821
- Briviact® [package insert]Smyrna, GAUCB, Inc2016
- Tegretol® [package insert]East Hanover, NJNovartis Pharmaceuticals Corporation2015
- JonesKLLacroRVJohnsonKAAdamsJPattern of malformations in the children of women treated with carbamazepine during pregnancyN Engl J Med198932025166116662725616
- WatersCHBelaiYGottPSShenPDe GiorgioCMOutcomes of pregnancy associated with antiepileptic drugsArch Neurol19945132502538129635
- JentinkJDolkHLoaneMAIntrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control studyBMJ2010341c658121127116
- WerlerMMAhrensKABoscoJLUse of antiepileptic medications in pregnancy in relation to risks of birth defectsAnn Epidemiol2011211184285021982488
- TomsonTBattinoDBonizzoniEDose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registryLancet Neurol20111060961721652013
- Clonazepam [package insert]Morgantown, WVMylan Pharmaceuticals Inc2014
- Valium® [package insert]Nutley, NJRoche Laboratories2008
- RementeriaJLBhattKWithdrawal symptoms in neonates from intrauterine exposure to diazepamJ Pediatr1977901123126830876
- KorenGPastuszakAItoSDrugs in pregnancyN Engl J Med199833816112811379545362
- RothmanKJFylerDCGoldblattAKreidbergMBExogenous hormones and other drug exposures of children with congenital heart diseaseAm J Epidemiol19791094433439443241
- HaramK“Floppy infant syndrome” and maternal diazepamLancet19772803861261371430
- CzeizelAESzegalBAJoffeJMRaczJThe effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspringNeurotoxicol Teratol199921215716710192276
- Lizcano-GilLAGarcia-CruzDSanchez-CoronaJOmphalocele-exstrophy-imperforate-anus-spina bifida (OEIS) complex in a male prenatally exposed to diazepamArch Med Res199526195967711456
- Aptiom® [package insert]Marlborough, MASunovion Pharmaceuticals Inc2015
- Zarontin® [package insert]Morris Plains, NJParke-Davis2009
- NakaneYOkumaTTakahashiRMulti-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in JapanEpilepsia19802166636807439133
- FabroSBrownNATeratogenic potential of anticonvulsantsN Engl J Med19793002212801281431703
- From the NIH: anticonvulsants found to have teratogenic potentialJAMA19812451367431626
- KoupJRRoseJQCohenMEEthosuximide pharmacokinetics in a pregnant patient and her newbornEpilepsia1978196535539104867
- SamrenEBvan DuijnCMKochSMaternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsyEpilepsia19973899819909579936
- Felbatol® [package insert]Somerset, NJMEDA Pharmaceuticals Inc2011
- AdusumalliVEYangJTWongKKKucharczykNSofiaRDFelbamate pharmacokinetics in the rat, rabbit, and dogDrug Metab Dispos1991196111611251687019
- WagnerMLFelbamate: a new antiepileptic drugAm J Hosp Pharm19945113165716667942890
- Neurontin® [package insert]New York, NYParke-Davis2015
- Molgaard-NielsenDHviidANewer-generation antiepileptic drugs and the risk of major birth defectsJAMA2011305191996200221586715
- ErogluCAllenNJSusmanMWGabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesisCell2009139238039219818485
- PicchiettiDLHensleyJGBainbridgeJLConsensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactationSleep Med Rev201522647725553600
- Vimpat® [package insert]Symrna, GAUCB Pharma Inc2014
- Lamictal® [package insert]Research Triangle Park, NCGlaxoSmithKline2010
- DolkHWangHLoaneMLamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomaliesNeurology201686181716172527053714
- MeadorKJPenovichPWhat is the risk of orofacial clefts from lamotrigine exposure during pregnancy?Neurology2008711070670718765647
- VajdaFJGrahamJRotenALanderCMO’BrienTJEadieMTeratogenicity of the newer antiepileptic drugs – the Australian experienceJ Clin Neurosci2012191575922104350
- Keppra® [package insert]Smyrna, GAUCB Pharma Inc2009
- TomsonTPalmRKallenKPharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactationEpilepsia20074861111111617381438
- MawhinneyECraigJMorrowJLevetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registersNeurology201380440040523303847
- Ativan®[package insert]Philadelphia, PABiovail Pharmaceuticals, Inc2007
- BonnotOVollsetSEGodetPFD’AmatoTRobertEMaternal exposure to lorazepam and anal atresia in newborns: results from a hypothesis-generating study of benzodiazepines and malformationsJ Clin Psychopharmacol200121445645811476134
- Celontin® [package insert]New York, NYParke-Davis2013
- Oxtellar XR® [package insert]Rockville, MDSupernus Pharmaceuticals Inc2012
- Trileptal® [package insert]East Hanover, NJNovartis Pharmaceuticals2014
- PienimakiPLampelaEHakkolaJArvelaPRaunioHVahakangasKPharmacokinetics of oxcarbazepine and carbamazepine in human placentaEpilepsia19973833093169070593
- Fycompa® [package insert]Teaneck, NJEisai Inc2015
- KallenBRobertEMastroiacovoPMartinez-FriasMLCastillaEECocchiGAnticonvulsant drugs and malformations is there a drug specificity?Eur J Epidemiol19895131362707392
- AndersonRCCardiac defects in children of mothers receiving anticonvulsant therapy during pregnancyJ Pediatr1976892318319940034
- AnnegersJFHauserWAElvebackLRAndersonVEKurlandLICongenital malformations and seizure disorders in the offspring of parents with epilepsyInt J Epidemiol197873241247721359
- Dilantin® [package insert]New York, NYParke-Davis2016
- Cerebyx® [package insert]New York, NYPfizer Labs2016
- DamMChristiansenJMunckOMygindKIAntiepileptic drugs: metabolism in pregnancyClin Pharmacokinet1979415362421411
- KnottCWilliamsCPReynoldsFPhenytoin kinetics during pregnancy and the puerperiumBr J Obstet Gynaecol19869310103010373790462
- KochenourNKEmeryMGSawchukRJPhenytoin metabolism in pregnancyObstet Gynecol19805655775827432728
- BardyAHHiilesmaaVKTeramoKGranstromMLTeratogenic risks of antiepileptic drugsBr Med J (Clin Res Ed)1981283630314051406
- LanderCMSmithMTChalkJBBioavailability and pharmacokinetics of phenytoin during pregnancyEur J Clin Pharmacol19842711051106489420
- MonsonRRRosenbergLHartzSCShapiroSHeinonenOPSloneDDiphenylhydantoin and selected congenital malformationsN Engl J Med197328920104910524742220
- Lyrica® [package insert]New York, NYParke-Davis2016
- VeibyGDaltveitAKEngelsenBAGilhusNEFetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancyJ Neurol2014261357958824449062
- Mysoline® [package insert]Aliso Viejo, CAValeant Pharmaceuticals2009
- MyhreSAWilliamsRTeratogenic effects associated with maternal primidone therapyJ Pediatr19819911601627252656
- Banzel® [package insert]Woodcliff Lake, NJEisai Inc2015
- Gabitril® [package insert]North Wales, PATeva Pharmaceuticals2015
- Topamax® [package insert]Titusville, NJOrtho Pharmaceutical Corporation2005
- Hernandez-DiazSMittendorfRSmithCRAssociation between topiramate and zonisamide use during pregnancy and low birth weightObstet Gynecol20141231212824463659
- HuntSRussellASmithsonWHTopiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy RegisterNeurology200871427227618645165
- Depakene® [package insert]North Chicago, ILAbbVie Inc2016
- ChristiansonALCheslerNKrombergJGFetal valproate syndrome: clinical and neuro-developmental features in two sibling pairsDev Med Child Neurol19943643613697512516
- AulthouseALHittDCThe teratogenic effects of valproic acid in human chondrogenesis in vitroTeratology19944932082178059428
- ThurstonJHHauhartREVitamins to prevent neural-tube defectsN Engl J Med199332822164116428338547
- Jager-RomanEDeichlAJakobSFetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidJ Pediatr1986108699710043086531
- BoussemartTBonneauDLevardGBerthierMOriotDOmphalocele in a newborn baby exposed to sodium valproate in uteroEur J Pediatr199515432202217758521
- HubertABonneauDCouetDBerthierMOriotDLarregueMAplasia cutis congenita of the scalp in an infant exposed to valproic acid in uteroActa Paediatr19948377897907949818
- LaegreidLKyllermanMHednerTHagbergBViggedahlGBenzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsyNeuropediatrics199324288927687042
- OmtzigtJGNauHLosFJPijpersLLindhoutDThe disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co-medication, and the presence of spina bifidaEur J Clin Pharmacol19924343813881451717
- SharonyRGarberAViskochilDPreaxial ray reduction defects as part of valproic acid embryofetopathyPrenat Diagn199313109099188309898
- LammerEJSeverLEOakleyGPJrTeratogen update: valproic acidTeratology19873534654733114906
- BjerkedalTCzeizelAGoujardJValproic acid and spina bifidaLancet19822830710966127554
- LangerBHaddadJGasserBMaubertMSchlaederGIsolated fetal bilateral radial ray reduction associated with valproic acid usageFetal Diagn Ther1994931551588060510
- ArdingerHHAtkinJFBlackstonRDVerification of the fetal valproate syndrome phenotypeAm J Med Genet19882911711853125743
- Nieto BarreraMRufo CamposMSiliestrom RibedMLPartial hydranencephaly in a child coincidental with intrauterine exposure to sodium valproateNeuropediatrics19942563343357770134
- MorrowJRussellAGuthrieEMalformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJ Neurol Neurosurg Psychiatry200677219319816157661
- ArtamaMAuvinenARaudaskoskiTIsojarviIIsojarviJAntiepileptic drug use of women with epilepsy and congenital malformations in offspringNeurology200564111874187815955936
- SamrenEBvan DuijnCMChristiaensGCHofmanALindhoutDAntiepileptic drug regimens and major congenital abnormalities in the offspringAnn Neurol199946573974610553991
- AdabNKiniUVintenJThe longer term outcome of children born to mothers with epilepsyJ Neurol Neurosurg Psychiatry200475111575158315491979
- MeadorKJBakerGABrowningNFoetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of ageBrain2011134Pt 239640421224309
- CohenMJMeadorKJBrowningNFetal antiepileptic drug exposure: adaptive and emotional/behavioral functioning at age 6 yearsEpilepsy Behav201329230831524012508
- Sabril® [package insert]Deerfield, ILLundbeck Inc2015
- SorriIHerrgardEViinikainenKPaakkonenAHeinonenSKalviainenROphthalmologic and neurologic findings in two children exposed to vigabatrin in uteroEpilepsy Res2005651–211712015941649
- Zonegran® [package insert]Teaneck, NJEisai Inc2006
- KondoTKanekoSAmanoYEgawaIPreliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsyEpilepsia19963712124212448956859
- National Institute for Health and Care ExcellenceEpilepsies: diagnosis and management2016 Available from: https://www.nice.org.uk/guidance/cg137Accessed June 20, 2016
- CramerJAGordonJSchachterSDevinskyOWomen with epilepsy: hormonal issues from menarche through menopauseEpilepsy Behav200711216017817662661